Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Relay Therapeutics (RLAY) Receivables - Net: 2020-2022

Historic Receivables - Net for Relay Therapeutics (RLAY) over the last 3 years, with Dec 2022 value amounting to $306,000.

  • Relay Therapeutics' Receivables - Net fell 12.45% to $211,000 in Q3 2023 from the same period last year, while for Sep 2023 it was $211,000, marking a year-over-year decrease of 12.45%. This contributed to the annual value of $306,000 for FY2022, which is 24.07% down from last year.
  • According to the latest figures from FY2022, Relay Therapeutics' Receivables - Net is $306,000, which was down 24.07% from $403,000 recorded in FY2021.
  • Relay Therapeutics' Receivables - Net's 5-year high stood at $75.0 million during FY2020, with a 5-year trough of $306,000 in FY2022.
  • Over the past 3 years, Relay Therapeutics' median Receivables - Net value was $403,000 (recorded in 2021), while the average stood at $25.2 million.
  • Data for Relay Therapeutics' Receivables - Net shows a maximum YoY slumped of 99.46% (in 2021) over the last 5 years.
  • Relay Therapeutics' Receivables - Net (Yearly) stood at $75.0 million in 2020, then tumbled by 99.46% to $403,000 in 2021, then fell by 24.07% to $306,000 in 2022.